How did XTNT's Q1 2025 EPS forecast compare to past trends?

Xtant Medical Holdings Inc (XTNT) is expected to report an EPS of $0 for Q1 2025, which is a significant improvement from the previous quarter's EPS of -$0.02. This indicates a potential turnaround in the company's financial performance. However, when comparing the Q1 2025 EPS forecast to the 5-year EPS CAGR, it is important to consider the overall trend of the company's earnings. The 5-year EPS CAGR for XTNT stock is not currently available. However, based on the available data, the 5-year revenue TTM CAGR for XTNT stock is 11.52%. This suggests that while the company's EPS may have fluctuated in the past, there has been a general upward trend in revenue, which could be a positive indicator for future earnings growth. In conclusion, while the Q1 2025 EPS forecast of $0 represents an improvement from the previous quarter, it is important to consider the broader context of the company's financial trends over the past 5 years. The 5-year revenue TTM CAGR of 11.52% indicates a positive outlook for the company's future earnings potential.